Crossmark

Midnolin is a novel regulator of parkin expression and is associated with Parkinson’s Disease

Published Online: 2017-07-19

Authors

Obara, Yutaro

Imai, Toru

Sato, Hidenori

Takeda, Yuji

Kato, Takeo

Ishii, Kuniaki
License Information

Text and Data Mining valid from 2017-07-19

Version of Record valid from 2017-07-19
More Information

Article History

Received: 7 April 2017

Accepted: 1 June 2017

First Online: 19 July 2017

Competing Interests

: The authors declare that they have no competing interests.

Document is current